Pharmacokinetics of radiotracers in human plasma during positron emission tomography
- PMID: 10502311
- DOI: 10.1002/(SICI)1098-2396(199911)34:2<124::AID-SYN5>3.0.CO;2-O
Pharmacokinetics of radiotracers in human plasma during positron emission tomography
Abstract
Many radiopharmaceuticals for positron emission tomography (PET) are substantially metabolized in peripheral organs. Pharmacological treatments intended to alter cerebral metabolism might also alter radiotracer metabolism, consequently altering the cerebral uptake. First-order rate constants for the metabolism of PET tracers can be calculated by a linear graphical method from the precursor and metabolite concentrations measured in plasma extracts fractionated by HPLC. We tested the effects of specific pharmacological challenges on the plasma kinetics of six tracers used for PET studies of neurotransmission. The rate of O-methylation of circulating [(18)F]fluorodopa, a tracer of dopa decarboxylase activity in brain, was unaffected by pretreatment with amantadine, an antagonist of glutamate receptors. [(11)C]Deprenyl, a tracer of monoamine oxidase activity, was rapidly metabolized to [(11)C]methamphetamine and polar metabolites in healthy volunteers. The net rate constant of this metabolism was three times higher in a group of subjects under treatment for epilepsy, consistent with induction of hepatic microsomal enzymes by antiepileptic drugs. [(11)C]Sch 23390, a ligand for dopamine D1 receptors, was rapidly metabolized to polar metabolites. The net rate constant of metabolism was unaffected by pretreatment with lorazepam. [(11)C]-(S)-Nicotine, a ligand for nicotinic receptors, was rapidly metabolized to [(11)C]-(S)-cotenine, which is less polar than the parent compound. Pretreatment with mazindol, a dopamine uptake inhibitor, was without effect on peripheral metabolism of [(11)C]-(S)-nicotine. [(11)C]WIN 35,428, a tropane derivative which labels dopamine uptake sites, was metabolized to a nonpolar metabolite, but so slowly that the rate constant of this process could not be calculated. [(11)C]Raclopride, a ligand for dopamine D2 receptors, was first metabolized to a nonpolar metabolite, which then yielded two hydrophilic metabolites. The initial metabolic step was substantially blocked by pretreatment with amphetamine, possibly indicative of competitive inhibition of microsomal oxidation. Together, these results indicate that the linear graphic method is useful for estimating the kinetics of the plasma metabolism of many widely used PET tracers. Drug-drug interactions were revealed in subjects treated with specific pharmacological agents prior to tracer administration.
Copyright 1999 Wiley-Liss, Inc.
Similar articles
-
In vivo vulnerability to competition by endogenous dopamine: comparison of the D2 receptor agonist radiotracer (-)-N-[11C]propyl-norapomorphine ([11C]NPA) with the D2 receptor antagonist radiotracer [11C]-raclopride.Synapse. 2004 Jun 1;52(3):188-208. doi: 10.1002/syn.20013. Synapse. 2004. PMID: 15065219
-
Potential of [(18)F]beta-CFT-FE (2beta-carbomethoxy-3beta-(4-fluorophenyl)-8-(2-[(18)F]fluoroethyl)nortropane) as a dopamine transporter ligand: A PET study in the conscious monkey brain.Synapse. 2004 Oct;54(1):37-45. doi: 10.1002/syn.20059. Synapse. 2004. PMID: 15300883
-
Acute neuroleptic stimulates DOPA decarboxylase in porcine brain in vivo.Synapse. 2001 Aug;41(2):172-5. doi: 10.1002/syn.1071. Synapse. 2001. PMID: 11400183
-
Compartmental analysis of dopa decarboxylation in living brain from dynamic positron emission tomograms.Synapse. 1998 May;29(1):37-61. doi: 10.1002/(SICI)1098-2396(199805)29:1<37::AID-SYN4>3.0.CO;2-C. Synapse. 1998. PMID: 9552174 Review.
-
The role of radiotracer imaging in Parkinson disease.Neurology. 2005 Jan 25;64(2):208-15. doi: 10.1212/01.WNL.0000149403.14458.7F. Neurology. 2005. PMID: 15668415 Review.
Cited by
-
Single time point quantitation of cerebral glucose metabolism by FDG-PET without arterial sampling.EJNMMI Res. 2023 Nov 30;13(1):104. doi: 10.1186/s13550-023-01049-3. EJNMMI Res. 2023. PMID: 38032409 Free PMC article.
-
Editorial: Nicotine and its derivatives in disorders of cognition: a challenging new topic of study.Front Neurosci. 2023 Jul 18;17:1252705. doi: 10.3389/fnins.2023.1252705. eCollection 2023. Front Neurosci. 2023. PMID: 37534040 Free PMC article. No abstract available.
-
Radiosynthesis, Preclinical, and Clinical Positron Emission Tomography Studies of Carbon-11 Labeled Endogenous and Natural Exogenous Compounds.Chem Rev. 2023 Jan 11;123(1):105-229. doi: 10.1021/acs.chemrev.2c00398. Epub 2022 Nov 18. Chem Rev. 2023. PMID: 36399832 Free PMC article. Review.
-
Impact of an Adenosine A2A Receptor Agonist and Antagonist on Binding of the Dopamine D2 Receptor Ligand [11C]raclopride in the Rodent Striatum.Mol Pharm. 2022 Aug 1;19(8):2992-3001. doi: 10.1021/acs.molpharmaceut.2c00450. Epub 2022 Jul 18. Mol Pharm. 2022. PMID: 35849844 Free PMC article.
-
Imaging Biomarkers for Monitoring the Inflammatory Redox Landscape in the Brain.Antioxidants (Basel). 2021 Mar 28;10(4):528. doi: 10.3390/antiox10040528. Antioxidants (Basel). 2021. PMID: 33800685 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous